• 170308
在此页面上
BCG009, a Fully Human Anti-IGF-1R Antibody, as a Second-Generation Therapeutic for the Indication of Thyroid Eye Disease (TED)
B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes
Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity.